Roland L. Bassett - Publications, H-index & Citations

Roland L. Bassett

Department of Biostatistics

64H指数

613论文数

1.9W被引数

收录论文 152

发表时间

AI-derived tumor-infiltrating lymphocytes enhance the prediction of pathologic complete response in early-stage triple-negative breast cancer 人工智能衍生的肿瘤浸润淋巴细胞增强了早期三阴性乳腺癌病理完全缓解的预测

npj Breast Cancer

IF7.6

2026-08-29

OAAI

Xiaoxi Pan; Caner Ercan; Zhongya Wang; Roland L. Bassett; Karina B. Pinao Gonzales; Gaiane M. Rauch; Beatriz E. Adrada; Rosalind P. Candelaria; Debu Tripathy; Jennifer K. Litton; Sharon H. Giordano; Vicente Valero; Banu Arun; Alyson Clayborn; Kiran Virani; Jason White; Qingqing Ding; Aysegul A. Sahin; William Fraser Symmans; Clinton Yam; Lei Huo; Yinyin Yuan

RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases RET驱动的骨保护素表达将甲状腺髓样癌与成骨性骨转移联系起来

Cell Reports Medicine

IF10.6

2026-08-27

OAAI

Rozita Bagheri-Yarmand; Gabriel M. Pagnotti; Joseph L. Kidd; David Avila Ramirez; null Trupti Trivedi; Leah Guerra; Zhongya Wang; Lucia Martinez Cruz; Jade M. Moehle; Yaashmin S. Jebaraj; Xinhai Wan; Jian H. Song; Roland L. Bassett; Sue-Hwa Lin; Mimi I. Hu; Steven I. Sherman; Marie-Claude Hofmann; Theresa A. Guise

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection 更正：接受新辅助免疫疗法和淋巴结清扫的临床N1期黑色素瘤患者的真实世界结局

Annals of Surgical Oncology

IF3.5

2026-04-24

OAAI

Joshua Herb; Roland L. Bassett; Carlos A. Torres-Cabala; Victor G. Prieto; Sapna P. Patel; Ashley M. Holder; Sarah B. Fisher; Anthony Lucci; Jennifer Wargo; Rodabe N. Amaria; Michael A. Davies; Isabella C. Glitza Oliva; Hussein A. Tawbi; Jennifer McQuade; Alexandra P. Ikeguchi; Michael K. Wong; Adi K. Diab; Jeffrey E. Gershenwald; Merrick I. Ross; Roi Weiser

The shifting landscape of germline RET pathogenic variants with the introduction of panel testing 随着基因检测面板的引入，生殖细胞RET致病性变异的演变格局

Surgery

IF2.7

2025-11-27

PREAI

Amblessed E. Onuma; Catherine M. Skefos; Marcy E. Richardson; Sarah Pasyar; Kirkpatrick B. Fergus; Roland L. Bassett; Mimi I. Hu; Nancy D. Perrier; Anastasios Maniakas; Mark Zafereo; Steven G. Waguespack; Julie A. Sosa; Elizabeth G. Grubbs

Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia SPEN突变的突变谱及其在慢性淋巴细胞白血病患者中的临床影响

Cancers 2025, Vol. 17, Page 3586

IF4.4

2025-11-06

OAAI

Priyatharsini Nirmalanantham; Andrés E. Quesada; Anindita Ghosh; Pei Lin; Chi Y. Ok; Richard K. Yang; Hong Fang; Sofia Garces; Rashmi Kanagal-Shamanna; Sanam Loghavi; Mark J. Routbort; Cameron Cheng Yin; Wang Wei; Sarah Pasyar; Roland Bassett; Siba El Hussein; Nitin Jain; Jan Burger; William G. Wierda; Sa Wang; Carlos Bueso-Ramos; Keyur P. Patel; Leonard Jeffrey Medeiros; Fatima Zahra Jelloul

Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study 曲妥珠单抗德鲁克替康（trastuzumab Deruxtecan）引起的肺炎发生率和风险因素：一项回顾性队列研究

Breast Cancer Research

IF5.6

2025-11-05

OAAI

Maria Azhar; Felipe Soto; Amber Su; Norma Alicia Vazquez Gonzalez; Kevin Bernal Medina; Alejandro Lizarraga Madrigal; Cesar Chavez Duran; Carlos Ignacio Rodriguez Reyna; Colin Chan; Girish S. Shroff; Roland L. Bassett; Sarah Pasyar; David Zhang; Vickie R. Shannon; Mehmet Altan; Melissa P. Mitchell; Funda Meric-Bernstam; Jason Mouabbi; Rashmi K. Murthy; Saadia A. Faiz; Lara Bashoura; Bora Lim; Ajay Sheshadri

A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)一项Ib/II期临床试验，研究在HER2阳性或HR阳性/HER2阴性炎性乳腺癌患者（包括III期和IV期疾病）中，将奈拉替尼加入标准疗法的新辅助治疗。

Therapeutic Advances in Medical Oncology

IF4.2

2025-10-14

OAAI

Bora Lim; Angela Marx; Megumi Kai; Angela Alexander; Roland Bassett; Wencai Ma; Jie Willey; Huiming Sun; Azadeh Nasrazadani; Mohammad M. Mohammad; Jianhua Zhang; Anthony Lucci; Susie X. Sun; Michael C. Stauder; Gary J. Whitman; Huong Le-Petross; Vicente Valero; Wendy A. Woodward; Rachel M. Layman

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma 淋巴细胞清除、肿瘤浸润淋巴细胞，以及高剂量与低剂量IL-2后给予pembrolizumab在转移性黑色素瘤患者中的应用

OncoImmunology

IF6.3

2025-08-15

OAAI

Merve Hasanov; Simin Kiany; Marie-Andrée Forget; Roland Bassett; Michael A. Davies; Adi Diab; Jeffrey E. Gershenwald; Isabella C. Glitza; Jeffrey E. Lee; Anthony Lucci; Jennifer L. McQuade; Sapna P. Patel; Merrick I. Ross; Hussein A. Tawbi; Jennifer A. Wargo; Michael K. Wong; Chantale Bernatchez; Patrick Hwu; Cara Haymaker; Rodabe N. Amaria

Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial 作者更正: 同种异体NK细胞与双特异性先天细胞衔接器治疗难治性复发性淋巴瘤: 1期试验

Nature Medicine

IF50

2025-06-26

PREAI

Yago Nieto; Pinaki Banerjee; Indreshpal Kaur; Rafet Basar; Ye Li; May Daher; Hind Rafei; Lucila N. Kerbauy; Mecit Kaplan; David Marin; Lori Griffin; Melissa Barnett; Roland Bassett; Nadima Uprety; Rejeena Shrestha; Francia Reyes Silva; Sanjida Islam; Christina Ganesh; Zephanie Borneo; Jeremy Ramdial; Alejandro Ramirez; Chitra Hosing; Amin Alousi; Uday Popat; Muzaffar Qazilbash; Sairah Ahmed; Swaminathan Iyer; Tania P. Sainz; Francisco Vega; Natalie W. Fowlkes; Karenza Alexis; Michael Emig; Andreas Harstrick; Andre Overesch; Elizabeth J. Shpall; Katayoun Rezvani

Circadian Rhythm in End-Of-Life Delirium: A Secondary Analysis of Two Randomized Controlled Trials 临终谵妄中的昼夜节律：两项随机对照试验的二次分析

Journal of Pain and Symptom Management

IF3.5

2025-04-14

PREAI

Sonal Admane; Sarah Pasyar; Roland Bassett; Eduardo Bruera; David Hui

Clinical and Radiological Features of Atypical Adrenal Masses-A Multicenter Retrospective Study

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2024-11-06

OAAI

Balderrama-Brondani, Vania; Al-Ward, Ruaa; Kiseljak-Vassiliades, Katja; Fishbein, Lauren; Dawes, Danielle; Hamidi, Oksana; Pishdad, Reza; Rodriguez, Juan Pablo Perdomo; Sukkari, Mohamad Anas; Grajo, Joseph R.; Ghayee, Hans Kumar; Bedrose, Sara; Bassett, Roland L.; Hamrahian, Amir H.; Habra, Mouhammed Amir

Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Very High-Risk AML/MDS: A Phase 2 Trial 大剂量分次马利兰、氟达拉滨、克拉屈滨、替莫唑胺和维奈克拉（Cladillac）预处理方案用于极高危AML/MDS：一项Ⅱ期临床试验

BLOOD

IF23.1

2024-11-05

PREAI

Popat, Uday; Bassett, Roland L.; Alousi, Amin M.; Alatrash, Gheath; Aljawai, Yosra M.; Bashir, Qaiser; Chen, George; Fingrut, Warren B.; Hosing, Chitra; Im, Jin S.; Kebriaei, Partow; Marin, David; Nieto, Yago; Olson, Amanda L.; Oran, Betul; Qazilbash, Muzaffar H.; Ramdial, Jeremy; Saini, Neeraj Y.; Smallbone, Portia; Srour, Samer A.; Valdez, Benigno C.; Champlin, Richard E.; Andersson, Borje S.; Shpall, Elizabeth J.

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA

BMC CANCER

IF3.4

2024-08-16

OAAI

Chen, Jennifer H.; Addanki, Sridevi; Roy, Dhruvajyoti; Bassett, Roland; Kalashnikova, Ekaterina; Spickard, Erik; Kuerer, Henry M.; Meas, Salyna; Sarli, Vanessa N.; Korkut, Anil; White, Jason B.; Rauch, Gaiane M.; Tripathy, Debu; Arun, Banu K.; Barcenas, Carlos H.; Yam, Clinton; Sethi, Himanshu; Rodriguez, Angel A.; Liu, Minetta C.; Moulder, Stacy L.; Lucci, Anthony

Longitudinal changes in the carotid arteries of head and neck cancer patients following radiation therapy: Results from a prospective serial imaging biomarker characterization study

RADIOTHERAPY AND ONCOLOGY

IF5.3

2024-06-01

OAAI

Koutroumpakis, Efstratios; Mohamed, Abdallah Sherif Radwan; Chaftari, Peter; Rosenthal, David I.; Gujral, Dorothy; Nutting, Christopher; Kamel, Serageldin; Naser, Mohamed A.; Kim, Peter; Bassett, Roland; Fuller, Clifton D.; Mouhayar, Elie

Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into ARness ''

CELL REPORTS MEDICINE

IF10.6

2024-06-01

OAAI

Lim, Bora; Seth, Sahil; Yam, Clinton; Huo, Lei; Fujii, Takeo; Lee, Jangsoon; Bassett, Roland; Nasser, Sara; Ravenberg, Lisa; White, Jason; Clayborn, Alyson; Guerra, Gil; Litton, Jennifer K.; Damodaran, Senthil; Layman, Rachel; Valero, Vicente; Tripathy, Debasish; Lewis, Michael; Dobrolecki, Lacey E.; Lei, Jonathan; Candelaria, Rosalind; Arun, Banu; Rauch, Gaiane; Zhao, Li; Zhang, Jianhua; Ding, Qingqing; Symmans, W. Fraser; Chang, Jeffrey T.; Thompson, Alastair M.; Moulder, Stacy L.; Ueno, Naoto T.

Antibody-Drug Conjugates (ADCs) in Breast Cancer: Real World Analysis of Outcomes

CANCER RESEARCH

IF16.6

2024-05-02

PREAI

Raghavendra, Akshara Singareeka; Wang, Zhongya; Bassett, Roland; Tripathy, Debu

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results (vol 9, pg 898, 2023)

NATURE MEDICINE

IF50

2024-04-22

OAAI

Glitza Oliva, Isabella C.; Ferguson, Sherise D.; Bassett, Roland; Foster, Alexandra P.; John, Ida; Hennegan, Tarin D.; Rohlfs, Michelle; Richard, Jessie; Iqbal, Masood; Dett, Tina; Lacey, Carol; Jackson, Natalie; Rodgers, Theresa; Phillips, Suzanne; Duncan, Sheila; Haydu, Lauren; Lin, Ruitao; Amaria, Rodabe N.; Wong, Michael K.; Diab, Adi; Yee, Cassian; Patel, Sapna P.; Mcquade, Jennifer L.; Fischer, Grant M.; Mccutcheon, Ian E.; O'Brien, Barbara J.; Tummala, Sudhakar; Debnam, Matthew; Guha-Thakurta, Nandita; Wargo, Jennifer A.; Carapeto, Fernando C. L.; Hudgens, Courtney W.; Huse, Jason T.; Tetzlaff, Michael T.; Burton, Elizabeth M.; Tawbi, Hussein A.; Davies, Michael A.

OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy induced deepening and durable responses without interleukin 2 (IL2) in patients (pts) with immune checkpoint inhibitor (ICI)-resistant unresectable or metastatic melanoma

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Amaria, Rodabe N.; McQuade, Jennifer L.; Davies, Michael A.; Oliva, Isabella C. Glitza; Jose, Steffy; Cressman, Erik N.; Clausell, Ashlynd L.; Bassett, Roland; Patel, Sapna; Diab, Adi; Tawbi, Hussein A.; Wong, Michael K.; Ikeguchi, Alexandra P.; Jagasia, Madan; Ramsingh, Giridharan; Prabhakar, Prakash; Duan, Raina; Hari, Parameswaran

Phase II study of pembrolizumab in conjunction with lymphodepletion, TIL ACT, and high- or low-dose IL-2 in patients with metastatic melanoma

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Hasanov, Merve; Kiany, Simin; Forget, Marie-Andree; Bassett, Roland L.; Davies, Michael A.; Diab, Adi; Gershenwald, Jeffrey E.; Glitza, Isabella C.; Lee, Jeffrey E.; Lucci, Anthony; McQuade, Jennifer L.; Patel, Sapna P.; Ross, Merrick I.; Tawbi, Hussein A.; Wargo, Jennifer; Wong, Michael K.; Bernatchez, Chantale; Hwu, Patrick; Haymaker, Cara; Amaria, Rodabe N.

A single dose of perioperative cefazolin disrupts the gut microbiome and immunity in patients (pts) with early-stage melanoma

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Fernandez, Estefania; Cass, Samuel; Seo, Yongwoo D.; Damania, Ashish V.; Meng, Xiaolong; Sahasrabhojane, Pranoti V.; Liu, Jiun Sheng; Liu, Wenbin; Chen, Yulong; Bassett, Roland L.; Shelburne, Samuel; Chang, Hsiu-Yin; Somaiya, Kinjal R.; Mungovan, Kristi S.; Malke, Jared C.; Matejka, Brenna; Fisher, Sarah B.; Lucci, Anthony; Lee, Jeffrey E.; Ross, Merrick I.; Gershenwald, Jeffrey E.; Sharma, Padmanee; Ajami, Nadim J.; Roland, Christina L.; Wargo, Jennifer A.; Keung, Emily Z.

研究方向